Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Targeting ERBB2/HER2 genetic alterations: an expanding therapeutic opportunity in gastrointestinal cancers
They can facilitate easier weight loss, provide personalized care, and generate increased motivation towards dietary changes
Frye et al
Compound identity at a glance Name: Retatrutide INN: LY3437943 Class: Triple incretin receptor agonist Structure: 39-amino-acid synthetic peptide Dosing interval: Once weekly (research protocols) Developer: Eli Lilly For the full molecular reference (molecular formula, molecular weight, CAS number and the 39-amino-acid sequence) see the Retatrutide molecular profile
Retrieved from Kataoka, J., Tassone, E., Misso, M., et al
US$ 24.44
US$ 27.67
US$ 21.42
US$ 28.30
US$ 28.26
US$ 20.68
